Skip to main content

SHLP2 vs Cortexin

A detailed comparison to help you understand the differences and choose the right peptide for your research goals.

SHLP2

SHLP2 (Small Humanin-Like Peptide 2) is a mitochondrial-derived peptide similar to humanin. It has shown insulin-sensitizing and cytoprotective effects in research, with potential metabolic benefits.

Full details →

Cortexin

Cortexin is a polypeptide complex derived from pig brain cortex, used clinically in Russia and Eastern Europe for neurological conditions including stroke recovery, traumatic brain injury, and cognitive decline.

Full details →

Side-by-Side Comparison

AspectSHLP2Cortexin
MechanismEnhances insulin sensitivity and glucose uptake. Provides cytoprotective effects similar to humanin. May act through similar but distinct receptor pathways.Contains a mixture of neuropeptides and amino acids that support neuronal metabolism, provide neuroprotection, and enhance synaptic transmission. Specific mechanisms not fully characterized.
Typical DosageResearch compound with doses in the microgram to low milligram range studied in animal models. Human dosing not established.Clinical protocols: 10mg intramuscularly once daily for 10-20 days. May be repeated after 3-6 month interval.
AdministrationSubcutaneous or intraperitoneal injection in research settings. Various SHLP analogs (1-6) have different properties.Intramuscular injection. Comes as lyophilized powder requiring reconstitution. Treatment given in courses rather than continuously.
Side EffectsLimited data. Animal studies suggest good tolerability. May affect glucose metabolism.Generally well-tolerated. May cause injection site reactions or mild allergic responses in sensitive individuals.
Best For

Key Differences

Detailed Analysis

Cortexin and SHLP2 are used for different purposes and have limited overlap in their applications.

Which Should You Choose?

Choose Cortexin for Recovery & Healing, Cognitive Performance. Choose SHLP2 for Fat Loss, Anti-Aging & Longevity.

Ready to Learn More?